The use of genetically engineered mouse models of prostate cancer for nutrition and cancer chemoprevention research
- 25 August 2005
- journal article
- review article
- Published by Elsevier BV in Mutation Research - Reviews in Mutation Research
- Vol. 576 (1-2), 111-119
- https://doi.org/10.1016/j.mrfmmm.2005.02.012
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- GENETICALLY MODIFIED MICE AND THEIR USE IN DEVELOPING THERAPEUTIC STRATEGIES FOR PROSTATE CANCERJournal of Urology, 2004
- Genetically defined mouse models that mimic natural aspects of human prostate cancer development.Endocrine-Related Cancer, 2004
- Prostate Pathology of Genetically Engineered Mice: Definitions and Classification. The Consensus Report from the Bar Harbor Meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology CommitteeCancer Research, 2004
- Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancerCancer Cell, 2003
- Myc-driven murine prostate cancer shares molecular features with human prostate tumorsCancer Cell, 2003
- Pathobiology of autochthonous prostate cancer in a pre‐clinical transgenic mouse modelThe Prostate, 2003
- Mouse Strains for Prostate Tumorigenesis Based on Genes Altered in Human Prostate CancerCurrent Drug Targets, 2003
- Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenolsProceedings of the National Academy of Sciences of the United States of America, 2001
- Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouseNature Genetics, 2001
- Deregulated expression of insulin-like growth factor 1 in prostate epithelium leads to neoplasia in transgenic miceProceedings of the National Academy of Sciences of the United States of America, 2000